Drug discovery is shifting from static snapshots to moving pictures. Instead of inferring how medicines work from end results ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced updated efficacy and safety ...
Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...
A research team of the University Medical Center Mainz has succeeded in observing for the first time how G protein-coupled ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...
Kanazawa University, in collaboration with Osaka University and the National Institutes for Quantum Science and Technology, ...
A shift in the balance between two lipids – cholesterol and sphingomyelin – makes hybrid epithelial-mesenchymal cancer cells less responsive to certain chemotherapy drugs.
It’s not just that minty tastes clash with sweet ones. Toothpaste contains the detergent sodium lauryl sulfate, which helps ...